Market Research Report

Global Human Milk Oligosaccharides (HMO) Market Research Report: Forecast (2023-2028)

By Type (2’FL, 3’FL, 3’SL, 6’SL), By Application (Infant formula, Functional food & beverage, Food supplements, Others), By Concentration (Neutral, Acidic, Others), By Dist...ribution Channel (Hypermarkets & Supermarkets, Drug store or pharmacy, Mass merchandiser, Departmental Stores, Mono-brand Store, Specialty stores), By Region (North America, South America, Europe, Asia-Pacific, The Middle East and Africa), By Company (Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd, DuPont Nutrition & Biosciences, Elicityl S.A., Glycosyn, Inbiose NV, Medolac Laboratories, Nestle Health Science, ROYAL DSM, BASF SE, Abbott Laboratories, GNUBIOTICS Sciences S.A., Dextra Laboratories, Others) Read more

  • Food & Beverages
  • May 2023
  • 179
  • PDF, Excel, PPT

Market Definition

Human Milk Oligosaccharides (HMOs) are a complex group of carbohydrates naturally present in human breast milk. After lactose and lipids, they are the third most abundant solid component in breast milk and are composed of various monosaccharides (simple sugars) linked together in different arrangements.

Market Insights & Analysis: Global Human Milk Oligosaccharides (HMO) Market (2023-28)

The Global Human Milk Oligosaccharides (HMO) Market is projected to grow at around 21.75% CAGR during the forecast period, i.e., 2023-28. The growth of the market would be propelled mainly by increasing concerns among consumers regarding health & wellness, growing awareness about the importance of optimal nutrition for infants as well as the benefits of HMOs. Besides, the ever-increased focus on infant health & development, coupled with technological advancements in HMO production methods, are other prominent aspects expected to drive the market in the future.

Report Coverage Details
Study Period Historical Data: 2018-21
Base Year: 2022
Forecast Period: 2023-28
CAGR (2023-2028) 21.75%
Regions Covered North America: The US, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
South America: Brazil, Argentina, Rest of South America
Middle East & Africa: The UAE, Saudi Arabia, South Africa, Rest of the Middle East & Africa
Key Companies Profiled Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd., DuPont Nutrition & Biosciences, Elicityl S.A., Glycosyn, Inbiose NV, Medolac Laboratories, Nestle Health Science, ROYAL DSM, BASF SE, Abbott Laboratories, GNUBIOTICS Sciences S.A., Dextra Laboratories, Others
Unit Denominations USD Million/Billion

 

Several companies operating in the industry are massively investing in R&D activities to develop new HMO types, improve production processes, and expand the range of applications in order to boost innovations & product development. The rising infant population, urbanization, increasing disposable incomes, and changing lifestyles continue to augment the demand for HMOs, and they are being increasingly incorporated into infant formula products to enhance their nutritional value and mimic the benefits of breast milk.

Moreover, favorable government policies toward encouraging the use of HMOs, the mounting demand for dietary supplements that help improve metabolic activity by promoting bacterial growth, and the increasing application of HMOs in pharmaceuticals, infant formulas, & medicinal foods are also anticipated to spur growth in the Global Human Milk Oligosaccharides (HMO) Market through 2028.


Global Human Milk Oligosaccharides (HMO) Market Research Report: Forecast (2023-2028)

Global Human Milk Oligosaccharides (HMO) Market Key Driver:

Increasing awareness of the Health Benefits of HMOs and the Rising Demand for Improved Infant Nutrition - There is a growing awareness of the crucial role of nutrition in early childhood development & long-term health outcomes. Since HMOs are naturally occurring components of breast milk, they have been linked to various health benefits, like a healthy gut microbiome, enhanced immunity, and protection against pathogens. This increased focus on infant health & nutrition is fueling the demand for HMOs in infant formula & baby food products worldwide. Numerous studies have cited the potential health benefits of HMOs for infants and created much evidence that supports the positive impact of HMOs on gut health, immune development, and overall well-being, which, in turn, has increased awareness & acceptance of HMOs among healthcare professionals, parents, & consumers. Hence, these factors are expected to drive the Global Human Milk Oligosaccharides (HMO) Market during 2023-28.

Global Human Milk Oligosaccharides (HMO) Market Growth Restraint:

High Production Cost of HMO-composed Supplements and Food Products - The natural abundance of HMOs in human milk is limited, which makes it challenging to extract sufficient quantities for commercial production. As a result, alternative production methods like microbial fermentation or enzymatic synthesis are employed, which involve multiple steps and require specific enzymes or microorganisms that are costly to develop & maintain. In addition, scaling up the HMO production from a laboratory to commercial-scale also poses significant challenges, as it requires optimizing production processes, ensuring consistent quality & purity, and managing large-scale fermentation or synthesis operations, which further increase the production costs and limit the availability of HMOs in the market. Hence, these aspects are projected to restrain the growth of the Global Human Milk Oligosaccharides (HMO) Market through 2028.

Global Human Milk Oligosaccharides (HMO) Market (2023-28): Segmentation Analysis

The Global Human Milk Oligosaccharides (HMO) Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2023–2028 at the global, regional, and national levels. Based on the Type, and Applicationthe market has been further classified as:

Based on Type:

  • 2’FL
  • 3’FL
  • 3’SL
  • 6’SL

Of them all, 2'-FL dominates the Global Human Milk Oligosaccharides (HMO) Market, mainly on account of its structural similarity to & abundance in human breast milk, owing to which it is extensively studied & successfully produced on a commercial scale globally. 2'-FL has been the subject of numerous scientific studies, which demonstrated its potential health benefits for infants, like the development of a healthy gut microbiome, strengthened immune system, and protection against pathogens.

It has also received regulatory approvals in several countries as a safe ingredient for use in infant formula & baby food products, which, consequently, has facilitated its incorporation into commercial products. Many companies have come up with different methods to produce 2'-FL through fermentation processes using specialized enzymes & microorganisms. Hence, as more & more infant formula manufacturers are increasingly incorporating 2'FL into their product offerings to cater to the ever-rising demand for infant formulas with HMOs, it is spurring growth in the Global Human Milk Oligosaccharides (HMO) Market.

Based on Application:

  • Infant Formula
  • Functional Food & Beverages
  • Food Supplements

Here, infant formula is the leading application for HMOs and is used extensively as a substitute for breast milk across various regions where breastfeeding rates are less. The demand for HMOs in designing infant formulas is rapidly increasing worldwide owing to their benefits, such as improved gut health, enhanced memory, brain development, infection prevention, and prebiotic effects. More & more manufacturers are incorporating HMOs into infant formula to enhance the nutritional value of their products and offer benefits similar to breast milk. Societal changes, the convenience of infant formula, and the rising number of working mothers worldwide are all driving the Human Milk Oligosaccharides (HMO) Market.

Global Human Milk Oligosaccharides (HMO) Market Regional Projection

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific

Of all regions globally, Asia-Pacific is projected to acquire a significant share of the Human Milk Oligosaccharides (HMO) Market during 2023-28. It owes mainly to the increasing population & urbanization, the rising awareness of breastfeeding benefits, and economic growth in several countries. Besides, the growing demand for infant formulas & functional beverages, the rapidly expanding dairy industry, and an increased focus on consuming nutritious foods are other prominent aspects fueling the regional market growth.

Asia-Pacific is witnessing a rapidly rising prevalence of chronic ailments like gut diseases, diabetes, high blood pressure, & rickets, i.e., leading to the ever-increasing demand for functional food & beverages, which, consequently, is augmenting the demand for HMOs across the region. Also, with a growing awareness of the importance & benefits of breastfeeding for infant health, there is an increased interest in infant formulas & baby food products to replicate the nutritional benefits of breast milk, including the addition of HMOs.

Several countries in the region have implemented regulations toward encouraging the use of HMOs in infant formulas in order to improve the quality of infant nutrition products and promote their health. The growing markets for dietary supplements & baby food, especially in countries like India & China, are also projected to contribute significantly to the Asia-Pacific Human Milk Oligosaccharides (HMO) Market over the coming years.

Global Human Milk Oligosaccharides (HMO) Industry Recent Developments 

  • On 18 November 2022, KYOWA HAKKO BIO CO. LTD., a subsidiary of Kirin Holdings Company, Limited, completed the HMO production facility at its Thai subsidiary, THAI KYOWA BIOTECHNOLOGIES CO., LTD.
  • On 31 October 2022, FrieslandCampina got approval from Australia’s & New Zealand’s authorities for using its 2’-FL trademarked Aequival in infant milk formula, i.e., in line with expanding its HMO portfolio.

Gain a Competitive Edge with Our Global Human Milk Oligosaccharides (HMO) Market Report

  1. Global Human Milk Oligosaccharides (HMO) Market report provides a detailed and thorough analysis of market size, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics and make informed decisions.
  2. This report also highlights current market trends and future projections, allowing businesses to identify emerging opportunities and potential challenges. By understanding market forecasts, companies can align their strategies and stay ahead of the competition.
  3. Global Human Milk Oligosaccharides (HMO) Market report aids in assessing and mitigating risks associated with entering or operating in the market.
  4. The report would help in understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks and optimize their operations.

Frequently Asked Questions

   A. The Human Milk Oligosaccharides (HMO) Market is expected to register around 21.75% CAGR during 2023-28.

   A. The ever-increasing awareness of the health benefits of HMOs and the growing demand for improved infant nutrition are the prime aspects projected to drive the Human Milk Oligosaccharides (HMO) Market during 2023-28.

   A. Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd., DuPont Nutrition & Biosciences, Elicityl S.A., Glycosyn, Inbiose NV, Medolac Laboratories, Nestle Health Science, ROYAL DSM, BASF SE, Abbott Laboratories, GNUBIOTICS Sciences S.A., and Dextra Laboratories are the key players operating in the Human Milk Oligosaccharides (HMO) Market.

   A. High production costs associated with HMO-composed supplements & food products are the major growth restraints for the Human Milk Oligosaccharides (HMO) Market.

   A. Infant Formula would continue generating lucrative prospects for the leading companies in the Human Milk Oligosaccharides (HMO) Market during 2023-28.

   A. Asia-Pacific would provide profitable opportunities to the Human Milk Oligosaccharides (HMO) Market over the forecast years.

Global Human Milk Oligosaccharides (HMO) Market Research Report (2023-2028) - Table of Contents

 

  1. Market Segmentation
  2. Introduction
    1. Type Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Human Milk Oligosaccharides (HMO) Market Regulations and Policy
  5. Global Human Milk Oligosaccharides (HMO) Market Trends & Developments
  6. Global Human Milk Oligosaccharides (HMO) Market Supply Chain Analysis
  7. Global Human Milk Oligosaccharides (HMO) Market Dynamics
    1. Drivers
    2. Challenges
  8. Global Human Milk Oligosaccharides (HMO) Market Hotspot & Opportunities
  9. Global Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type
        1. 2’FL- Market Size & Forecast 2018-2028, (USD Million)
        2. 3’FL- Market Size & Forecast 2018-2028, (USD Million)
        3. 3’SL- Market Size & Forecast 2018-2028, (USD Million)
        4. 6’SL- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application
        1. Infant formula- Market Size & Forecast 2018-2028, (USD Million)
        2. Functional food & beverage- Market Size & Forecast 2018-2028, (USD Million)
        3. Food supplements- Market Size & Forecast 2018-2028, (USD Million)
        4. Others-Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration
        1. Neutral- Market Size & Forecast 2018-2028, (USD Million)
        2. Acidic- Market Size & Forecast 2018-2028, (USD Million)
        3. Others-- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel
        1. Hypermarkets & Supermarkets- Market Size & Forecast 2018-2028, (USD Million)
        2. Drug store or pharmacy- Market Size & Forecast 2018-2028, (USD Million)
        3. Mass merchandiser- Market Size & Forecast 2018-2028, (USD Million)
        4. Departmental Stores- Market Size & Forecast 2018-2028, (USD Million)
        5. Mono-brand Store-Market Size & Forecast 2018-2028, (USD Million)
        6. Specialty stores-Market Size & Forecast 2018-2028, (USD Million)
      5. By Region
        1. North America
        2. South America
        3. Europe
        4. Asia-Pacific
        5. The Middle East and Africa
      6. By Company
        1. Market Share
        2. Competition Characteristics
  10. North America Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
      5. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2018-2028, (USD Million)
        2. By Application- Market Size & Forecast 2018-2028, (USD Million)
        3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
        4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
    4. Canada Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2018-2028, (USD Million)
        2. By Application- Market Size & Forecast 2018-2028, (USD Million)
    5. Mexico Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2018-2028, (USD Million)
        2. By Application- Market Size & Forecast 2018-2028, (USD Million)
        3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
        4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  11. South America Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    3. Brazil Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2018-2028, (USD Million)
        2. By Application- Market Size & Forecast 2018-2028, (USD Million)
        3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
        4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
    4. Argentina Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2018-2028, (USD Million)
        2. By Application- Market Size & Forecast 2018-2028, (USD Million)
        3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
        4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  12. Europe Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
    3. By Country
      1. Germany
      2. The UK
      3. France
      4. Italy
      5. Spain
      6. Rest of Europe
  13. Germany Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  14. The UK Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  15. France Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  16. Italy Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  17. Spain Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  18. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
    3. By Country
      1. China
      2. Japan
      3. Australia
      4. India
      5. South Korea
      6. Rest of Asia Pacific
  19. China Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  20. Japan Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  21. Australia Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  22. India Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  23. South Korea Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  24. Middle East and Africa Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
    3. By Country
      1. South Africa
      2. The UAE
      3. Saudi Arabia
      4. Rest of Middle East and Africa
  25. South Africa Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  26. The UAE Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  27. Saudi Arabia Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2018-2028, (USD Million)
      2. By Application- Market Size & Forecast 2018-2028, (USD Million)
      3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
      4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  28. Competitive Outlook
    1. Company Profiles 
      1.  Biosynth Carbosynth
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Chr. Hansen Holding A/S
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3.  Dextra Laboratories Ltd
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. DuPont Nutrition & Biosciences
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Elicityl S.A.
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Glycosyn
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Inbiose NV
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Medolac Laboratories
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Nestle Health Science
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. ROYAL DSM
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. BASF SE
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Abbott Laboratories
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. GNUBIOTICS Sciences S.A.
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Dextra Laboratories
        1. Business Description
        2. Type Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. Others
        1. Conagen Inc.
        2. Medolac Laboratories
  29. Disclaimer


Human Milk Oligosaccharides (HMO) Market - Segmentation
Place an order
Only market data will be provided in the excel spreadsheet.

USD 3,700
USD 2,960

The report will be delivered in PDF format without printing rights. It is advised for a single user.

USD 4,850
USD 3,880

The report will be delivered in PDF format with printing rights. It is advised for up to five users.

USD 6,000
USD 4,800

The report will be delivered in PDF format with printing rights and excel sheet. It is advised for companies where multiple users would like to access the report from multiple locations

USD 7,500
USD 5,250

Request Sample Talk to our Consultant Request Customization
Related Reports